BNP Paribas Fortis

Manufacturer of artificial intelligence-powered smart lamps intended to enable elderly people to live at their desired place for as long as possible. The company designs lamps that have the technology to detect falls and can, if needed, contact family or caregivers, the subtly designed lamps provide peace of mind for seniors and their families while enhancing care and communication, enabling old aged people to get home care technology.

Itsme is a secure mobile application that facilitates safe digital interactions by enabling users to verify their identity and approve transactions. The platform offers a range of services, including logging in to various online accounts, confirming payments, accessing government applications, and digitally signing official documents. By assigning a unique ID for transaction confirmation, Itsme enhances user privacy while navigating online portals, ensuring a reliable and user-friendly experience for those seeking secure digital authentication.

PaxFamilia is a digital wealth management platform providing advanced solutions and advising tools to advisors who serve clients with substantial wealth. Every day, our team of 20 specialists is committed to offering a secure and easy-to-use platform that aggregates and contextualises all kinds of wealth data, provides state-of-the-art advising tools and offers the possibility to store documents and produce attractive reports. With PaxFamilia, advisors dispose of a structured information base that helps them get a crystal-clear picture of their clients’ wealth situation. As a consequence, PaxFamilia is a great and indispensable software for them to produce accurate and goal-based advice and to become the trusted advisor of their clients.

XenomatiX develops automotive Lidar solutions.

Dockflow BVBA develops digital solutions for sharing maritime shipping information. The company offers container tracking platform that offers features, such as document sharing, shipment status, temperature monitoring, and GPS location tracking. Its platform enables customers to get access of their supply chain partners and track their shipments, monitor temperatures, and receive alerts. The company also offers consulting services for digitalization of logistic function. Dockflow BVBA was founded in 2018 and is based in Antwerp, Belgium.

reMYND NV is engaged in the development of disease-modifying treatments for Alzheimer's, Parkinson's, diabetes, and other disorders associated with protein misfolding and cellular dysfunction. The company's investigational compounds include ReS19-T for Alzheimer's, ReS39 for diabetes, and ReS3-T, which targets neuronal hyperactivity in Alzheimer's and epilepsy. Additionally, reMYND provides a phenotypic screening platform to discover small molecule treatments that counteract toxicity from misfolded proteins, like Tau and Synuclein. The company operates as a contract research organization (CRO), offering services to assess the effects of experimental Alzheimer's treatments using proprietary transgenic mouse models. It has supported numerous pharmaceutical clients, including several from the top ten global companies, by providing critical in-vivo proof-of-concept data for candidate drugs in clinical development. Founded in 2002, reMYND is based in Leuven, Belgium, and serves clients primarily in the United States, Europe, and Japan.

MobieTrain NV is a company based in Antwerp, Belgium, founded in 2014, that specializes in mobile learning solutions for the retail and finance sectors. Its flagship product, the MobieTrain platform, utilizes artificial intelligence to deliver personalized and gamified training experiences for employees. The platform focuses on enhancing employee engagement through customized courses while also providing a comprehensive dashboard for tracking, analysis, and optimization of training outcomes. By tailoring learning experiences to the needs of individual employees, MobieTrain aims to transform traditional training methods and improve workforce effectiveness.

Dockflow BVBA develops digital solutions for sharing maritime shipping information. The company offers container tracking platform that offers features, such as document sharing, shipment status, temperature monitoring, and GPS location tracking. Its platform enables customers to get access of their supply chain partners and track their shipments, monitor temperatures, and receive alerts. The company also offers consulting services for digitalization of logistic function. Dockflow BVBA was founded in 2018 and is based in Antwerp, Belgium.

Provider of broadband services. The company operates a fiber-to-the-building broadband network offering speeds from 200 Mbps to 1000 Mbps.

reMYND NV is engaged in the development of disease-modifying treatments for Alzheimer's, Parkinson's, diabetes, and other disorders associated with protein misfolding and cellular dysfunction. The company's investigational compounds include ReS19-T for Alzheimer's, ReS39 for diabetes, and ReS3-T, which targets neuronal hyperactivity in Alzheimer's and epilepsy. Additionally, reMYND provides a phenotypic screening platform to discover small molecule treatments that counteract toxicity from misfolded proteins, like Tau and Synuclein. The company operates as a contract research organization (CRO), offering services to assess the effects of experimental Alzheimer's treatments using proprietary transgenic mouse models. It has supported numerous pharmaceutical clients, including several from the top ten global companies, by providing critical in-vivo proof-of-concept data for candidate drugs in clinical development. Founded in 2002, reMYND is based in Leuven, Belgium, and serves clients primarily in the United States, Europe, and Japan.

Quality Assistance S.A. is a prominent contract research organization based in Thuin, Belgium, specializing in analytical services for the pharmaceutical industry. Founded in 1982, the company provides a comprehensive suite of services crucial for the development and marketing of innovative human medicinal products. Its offerings include the analysis of new chemical entities, proteins, peptides, and vaccines, alongside specialized services in bioanalysis, mass spectrometry, and microbiology. Quality Assistance is equipped to conduct candidate selection, non-clinical and clinical studies, as well as marketing authorization, all in compliance with EMA and FDA regulations. The company prides itself on having all its laboratories situated on a single site, staffed by 150 highly qualified professionals with over 30 years of expertise in analytical sciences. Quality Assistance serves a diverse clientele, including pharmaceutical groups and biotechnology companies across Europe and the United States.

Ogeda SA, a clinical-stage drug discovery company, invents and develops small molecule drugs targeting G-Protein Coupled Receptors. It offers fezolinetant (ESN364), a Phase II clinical development product for the treatment of women’s health disorders; NK3 antagonists for the treatment of hormone-dependent pathologies in women's health; and products for endocrine, CNS/inflammatory disorders. Ogeda SA was formerly known as Euroscreen SA and changed its name to Ogeda SA in October 2016. The company was founded in 1994 and is based in Gosselies, Belgium. It has a meeting facility in Brussels, Belgium; and an additional office in Paris, France. Ogeda SA operates as a subsidiary of Astellas Pharma Inc.